Axon Enterprise, Inc $AXON Position Boosted by HighTower Advisors LLC

HighTower Advisors LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 4.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,601 shares of the biotechnology company’s stock after purchasing an additional 1,997 shares during the quarter. HighTower Advisors LLC owned 0.06% of Axon Enterprise worth $32,726,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at $29,000. Whipplewood Advisors LLC raised its position in shares of Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the period. Darwin Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the second quarter valued at $37,000. Root Financial Partners LLC purchased a new stake in shares of Axon Enterprise during the third quarter valued at $34,000. Finally, NewSquare Capital LLC increased its stake in Axon Enterprise by 96.2% in the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after purchasing an additional 25 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on AXON shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price objective on the stock in a research report on Tuesday, January 6th. UBS Group reduced their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Finally, Barclays dropped their price target on Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Axon Enterprise Stock Down 0.4%

AXON opened at $430.12 on Thursday. The company has a market capitalization of $33.94 billion, a PE ratio of 136.11, a price-to-earnings-growth ratio of 13.01 and a beta of 1.48. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. Axon Enterprise, Inc has a fifty-two week low of $396.41 and a fifty-two week high of $885.91. The business has a 50-day moving average of $550.04 and a 200-day moving average of $641.48.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the transaction, the president directly owned 249,502 shares of the company’s stock, valued at $137,874,805.20. This represents a 7.42% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Jennifer H. Mak sold 1,134 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the completion of the sale, the chief accounting officer directly owned 13,740 shares of the company’s stock, valued at $8,244,000. This represents a 7.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 48,040 shares of company stock valued at $27,249,338. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.